96 related articles for article (PubMed ID: 3651856)
21. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
[TBL] [Abstract][Full Text] [Related]
22. Results of drug monitoring with Ditec aerosol in patients with chronic obstructive airway diseases.
Stauder J; Köhler ME; Stechert R
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):472. PubMed ID: 1490786
[No Abstract] [Full Text] [Related]
23. Preliminary study of the effects of postoperative methylprednisolone therapy on lung function recovery in patients with chronic obstructive pulmonary disease.
Fraser IM; Hyland RH; Hutcheon MA; MacKenzie RL; Ameli FM; Provan JL
Clin Pharm; 1989 Mar; 8(3):214-9. PubMed ID: 2706894
[No Abstract] [Full Text] [Related]
24. The site of action of beta-2-sympathomimetic bronchodilatators in patients with chronic obstructive airway disease.
Nassari W; Zimmermann I; Bouzrina S; Ulmer WT
Respiration; 1981; 41(4):232-8. PubMed ID: 7302389
[TBL] [Abstract][Full Text] [Related]
25. The one best test for evaluating the effects of bronchodilator therapy.
Light RW; Conrad SA; George RB
Chest; 1977 Oct; 72(4):512-6. PubMed ID: 908220
[No Abstract] [Full Text] [Related]
26. Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction.
Lucena MI; Almagro J; Rius F; Sanchez de la Cuesta F
Eur J Clin Pharmacol; 1988; 35(6):669-71. PubMed ID: 3234474
[TBL] [Abstract][Full Text] [Related]
27. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
Langaker O
Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
[No Abstract] [Full Text] [Related]
28. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
Morr H; Nink M; Ferlinz R
Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
[TBL] [Abstract][Full Text] [Related]
29. Is aminophylline useful in chronic obstructive pulmonary disease? When should corticosteroids be used?
Figueroa Lebrón R
Bol Asoc Med P R; 1988 Sep; 80(9):340. PubMed ID: 3190844
[No Abstract] [Full Text] [Related]
30. Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
Clark CJ; Boyd G
Br J Clin Pharmacol; 1980 Apr; 9(4):359-64. PubMed ID: 7378251
[TBL] [Abstract][Full Text] [Related]
31. Pressurized bronchodilator aerosol technique: influence of breath-holding time and relationship of inhaler to the mouth.
Lawford P; McKenzie
Br J Dis Chest; 1982 Jul; 76(3):229-33. PubMed ID: 7126435
[No Abstract] [Full Text] [Related]
32. [Effect of slow-release aminophylline on pulmonary function in obstructive respiratory disease(author's transl)].
Wiessmann KJ
Dtsch Med Wochenschr; 1975 Sep; 100(36):1781-90. PubMed ID: 1098887
[TBL] [Abstract][Full Text] [Related]
33. [The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy].
Borkenstein J
Acta Med Austriaca; 1979; 6(1):5-7. PubMed ID: 116469
[TBL] [Abstract][Full Text] [Related]
34. [Bronchodilator effectiveness of theophylline].
Kleinemeier HJ; Höltmann B; Schwabl U; Schwabl H; Ulmer WT
Fortschr Med; 1988 Aug; 106(24):499-502. PubMed ID: 2975627
[No Abstract] [Full Text] [Related]
35. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
[TBL] [Abstract][Full Text] [Related]
36. Aminophylline and its influence on ventilatory endurance in humans.
Belman MJ; Sieck GC; Mazar A
Am Rev Respir Dis; 1985 Feb; 131(2):226-9. PubMed ID: 3970454
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
[TBL] [Abstract][Full Text] [Related]
38. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
Baronti A; Lelli M; Manini G; Verdiani P
Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
Jenne JW; Wyze MS; Rood FS; MacDonald FM
Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
[No Abstract] [Full Text] [Related]
40. Clinical experience with a bronchospasmolytic aerosol combination.
Forche G; Harnoncourt K
Z Erkr Atmungsorgane; 1986; 166(1):47-52. PubMed ID: 2937212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
